Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...
Business Wire1mon
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
Effective today, additional health systems can connect via Aura to order GeneDx’s tests including exome sequencing (ES), whole genome sequencing (WGS) and rapid whole genome sequencing (rWGS).